Erratum: Impact of high-fat feeding on basic helix-loop-helix transcription factors controlling enteroendocrine cell differentiation (International Journal of Obesity (2014) DOI: 10.1038/ijo.2014.20);Impact of high-fat feeding on basic helix-loop-helix transcription factors controlling enteroendocrine cell differentiation

International Journal of Obesity

Volumn 38, Issue 11, 2014, Pages 1440-1448

  Sakar, Y ^a,b   Duca, F A ^a,b   Langelier, B ^a,b   Devime, F ^a,b   Blottiere, H ^a,b   Delorme, C ^a,b   Renault, P ^a,b   Covasa, M ^a,b,c,d  

^a UMR1319 MICALIS   (France)

^b AGROPARISTECH   (France)

^c WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^d STEFAN CEL MARE UNIVERSITY OF SUCEAVA   (Romania)

Author keywords

Enteroendocrine cells; GLP 1; Gut peptides; Intestinal chemosensation

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CARBOHYDRATE; GASTROINTESTINAL HORMONE; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; HEPATOCYTE NUCLEAR FACTOR 3BETA; LIPID; NEUROGENIC DIFFERENTIATION FACTOR; NEUROGENIN 3; FAT INTAKE;

ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ENTEROENDOCRINE CELL; FAT INTAKE; GENE EXPRESSION; GOBLET CELL; HYPERPHAGIA; IMMUNOFLUORESCENCE; INTESTINE CELL; LIPID DIET; MALE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SMALL INTESTINE; UPREGULATION; ADVERSE EFFECTS; ANIMAL; CALORIC INTAKE; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; ENERGY METABOLISM; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SECRETION (PROCESS); SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOTTING, WESTERN; CELL DIFFERENTIATION; DIET, HIGH-FAT; DIETARY FATS; DISEASE MODELS, ANIMAL; ENERGY INTAKE; ENERGY METABOLISM; ENTEROENDOCRINE CELLS; GASTROINTESTINAL HORMONES; HYPERPHAGIA; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; OBESITY; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84910150675     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2014.54     Document Type: Erratum

References (56)

1. Gerbe F, van Es JH, Makrini L, Brulin B, Mellitzer G, Robine S et al. Distinct ATOH1 and Neurog3 requirements define tuft cells as a new secretory cell type in the intestinal epithelium. J Cell Biol 2011; 192: 767-780.
2. Murphy KG, Bloom SR. Gut hormones and the regulation of energy homeostasis. Nature 2006; 444: 854-859.
3. Crosnier C, Stamataki D, Lewis J. Organizing cell renewal in the intestine: stem cells, signals and combinatorial control. Nat Rev Genet 2006; 7: 349-359.
4. Duca FA, Sakar Y, Covasa M. Combination of obesity and high-fat feeding diminishes sensitivity to GLP-1R agonist, Exendin-4. Diabetes 2013; 62: 2410-2415.
5. Schonhoff SE, Giel-Moloney M, Leiter AB. Minireview: development and differentiation of gut endocrine cells. Endocrinology 2004; 145: 2639-2644.
6. Moran GW, Leslie FC, Levison SE, Worthington J, McLaughlin JT. Enteroendocrine cells: neglected players in gastrointestinal disorders? Therap Adv Gastroenterol 2008; 1: 51-60.
7. Crosnier C, Vargesson N, Gschmeissner S, Ariza-McNaughton L, Morrison A, Lewis J. Delta-Notch signalling controls commitment to a secretory fate in the zebrafish intestine. Development 2005; 132: 1093-1104.
8. Ogaki S, Shiraki N, Kume K, Kume S. Wnt and notch signals guide embryonic stem cell differentiation into the intestinal lineages. Stem Cells 2013; 31: 1086-1096.
9. Bar Y, Russ HA, Knoller S, Ouziel-Yahalom L, Efrat S. HES-1 is involved in adaptation of adult human beta-cells to proliferation in vitro. Diabetes 2008; 57: 2413-2420.
10. Fujimori M, Ikeda S, Shimizu Y, Okajima M, Asahara T. Accumulation of beta-catenin protein and mutations in exon 3 of beta-catenin gene in gastrointestinal carcinoid tumor. Cancer Res 2001; 61: 6656-6659.
11. Li HJ, Ray SK, Singh NK, Johnston B, Leiter AB. Basic helix-loop-helix transcription factors and enteroendocrine cell differentiation. Diabetes Obes Metab 2011; 13: 5-12.
12. Yang Q, Bermingham NA, Finegold MJ, Zoghbi HY. Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science 2001; 294: 2155-2158.
13. VanDussen KL, Samuelson LC. Mouse atonal homolog 1 directs intestinal progenitors to secretory cell rather than absorptive cell fate. Dev Biol 2010; 346: 215-223.
14. Schonhoff SE, Giel-Moloney M, Leiter AB. Neurogenin 3-expressing progenitor cells in the gastrointestinal tract differentiate into both endocrine and non-endocrine cell types. Dev Biol 2004; 270: 443-454.
15. Jenny M, Uhl C, Roche C, Duluc I, Guillermin V, Guillemot F et al. Neurogenin3 is differentially required for endocrine cell fate specification in the intestinal and gastric epithelium. EMBO J 2002; 21: 6338-6347.
16. Ye DZ, Kaestner KH. Foxa1 and Foxa2 control the differentiation of goblet and enteroendocrine L- and D-cells in mice. Gastroenterology 2009; 137: 2052-2062.
17. Ratineau C, Petry MW, Mutoh H, Leiter AB. Cyclin D1 represses the basic helix-loop-helix transcription factor, BETA2/NeuroD. J Biol Chem 2002; 277: 8847-8853.
18. Beucher A, Gjernes E, Collin C, Courtney M, Meunier A, Collombat P et al. The homeodomain-containing transcription factors Arx and Pax4 control enteroendocrine subtype specification in mice. PLoS One 2012; 7: e36449.
19. Lopez-Diaz L, Jain RN, Keeley TM, VanDussen KL, Brunkan CS, Gumucio DL et al. Intestinal Neurogenin 3 directs differentiation of a bipotential secretory progenitor to endocrine cell rather than goblet cell fate. Dev Biol 2007; 309: 298-305.
20. Pearl EJ, Jarikji Z, Horb ME. Functional analysis of Rfx6 and mutant variants associated with neonatal diabetes. Dev Biol 2011; 351: 135-145.
21. Gniuli D, Castagneto-Gissey G, Iaconelli A, Leccesi L, Mingrone G. Fat mass largely contributes to insulin mediated glucose uptake in morbidly obese subjects. Int J Obes (Lond) 2010; 34: 1726-1732.
22. Hyland NP, Pittman QJ, Sharkey KA. Peptide YY containing enteroendocrine cells and peripheral tissue sensitivity to PYY and PYY(3-36) are maintained in dietinduced obese and diet-resistant rats. Peptides 2007; 28: 1185-1190.
23. Mumphrey MB, Patterson LM, Zheng H, Berthoud HR. Roux-en-Y gastric bypass surgery increases number but not density of CCK-, GLP-1-, 5-HT-, and neurotensin-expressing enteroendocrine cells in rats. Neurogastroenterol Motil 2012; 25: e70-e79.
24. Gniuli D, Calcagno A, Dalla Libera L, Calvani R, Leccesi L, Caristo ME et al. High-fat feeding stimulates endocrine, glucose-dependent insulinotropic polypeptide (GIP)-expressing cell hyperplasia in the duodenum of Wistar rats. Diabetologia 53: 2233-2240.
25. Soyer J, Flasse L, Raffelsberger W, Beucher A, Orvain C, Peers B et al. Rfx6 is an Ngn3-dependent winged helix transcription factor required for pancreatic islet cell development. Development 2009; 137: 203-212.
26. Swartz TD, Duca FA, de Wouters T, Sakar Y, Covasa M. Up-regulation of intestinal type 1 taste receptor 3 and sodium glucose luminal transporter-1 expression and increased sucrose intake in mice lacking gut microbiota. Br J Nutr 2011; 107: 621-630.
27. Duca FA, Swartz TD, Sakar Y, Covasa M. Increased oral detection, but decreased intestinal signaling for fats in mice lacking gut microbiota. PLoS One 2012; 7: e39748.
28. Turner JR. Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application. Am J Pathol 2006; 169: 1901-1909.
29. Covasa M. Deficits in gastrointestinal responses controlling food intake and body weight. Am J Physiol Regul Integr Comp Physiol 2010; 299: R1423-R1439.
30. Mao J, Hu X, Xiao Y, Yang C, Ding Y, Hou N et al. Overnutrition stimulates intestinal epithelium proliferation through beta-catenin signaling in obese mice. Diabetes 2013; 62: 3736-3746.
31. Duca FA, Swartz TD, Sakar Y, Covasa M. Decreased intestinal nutrient response in diet-induced obese rats: role of gut peptides and nutrient receptors. Int J Obes (Lond) 2012; 37: 375-381.
32. de Santa Barbara P, van den Brink GR, Roberts DJ. Development and differentiation of the intestinal epithelium. Cell Mol Life Sci 2003; 60: 1322-1332.
33. Lee JC, Smith SB, Watada H, Lin J, Scheel D, Wang J et al. Regulation of the pancreatic pro-endocrine gene neurogenin3. Diabetes 2001; 50: 928-936.
34. Gu D, Wang Z, Dou X, Zhang X, Li S, Vu L et al. Inhibition of ERK1/2 pathway suppresses adiponectin secretion via accelerating protein degradation by Ubiquitin-proteasome system: relevance to obesity-related adiponectin decline. Metabolism 2013; 62: 1137-1148.
35. Huang HP, Liu M, El-Hodiri HM, Chu K, Jamrich M, Tsai MJ. Regulation of the pancreatic islet-specific gene BETA2 (neuroD) by neurogenin 3. Mol Cell Biol 2000; 20: 3292-3307.
36. Smith SB, Gasa R, Watada H, Wang J, Griffen SC, German MS. Neurogenin3 and hepatic nuclear factor 1 cooperate in activating pancreatic expression of Pax4. J Biol Chem 2003; 278: 38254-38259.
37. Naya FJ, Huang HP, Qiu Y, Mutoh H, DeMayo FJ, Leiter AB et al. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. Genes Dev 1997; 11: 2323-2334.
38. Miyamoto Y, Miyamoto M. Immunohistochemical localizations of secretin, cholecystokinin, and somatostatin in the rat small intestine after acute cisplatin treatment. Exp Mol Pathol 2004; 77: 238-245.
39. Hill ME, Asa SL, Drucker DJ. Essential requirement for Pax6 in control of enteroendocrine proglucagon gene transcription. Mol Endocrinol 1999; 13: 1474-1486.
40. Suzuki K, Harada N, Yamane S, Nakamura Y, Sasaki K, Nasteska D et al. Transcriptional regulatory factor X6 (Rfx6) increases gastric inhibitory polypeptide (GIP) expression in enteroendocrine K-cells and is involved in GIP hypersecretion in high fat diet-induced obesity. J Biol Chem 2012; 288: 1929-1938.
41. Vollmer K, Holst JJ, Baller B, Ellrichmann M, Nauck MA, Schmidt WE et al. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance. Diabetes 2008; 57: 678-687.
42. Kamoi K, Shinozaki Y, Furukawa K, Sasaki H. Potential correlation between plasma total GIP levels and body mass index in Japanese patients with types 1 or 2 diabetes mellitus. Endocr J 2012; 59: 353-363.
43. Gniuli D, Calcagno A, Dalla Libera L, Calvani R, Leccesi L, Caristo ME et al. High-fat feeding stimulates endocrine, glucose-dependent insulinotropic polypeptide (GIP)-expressing cell hyperplasia in the duodenum of Wistar rats. Diabetologia 2010; 53: 2233-2240.
44. Porat S, Weinberg-Corem N, Tornovsky-Babaey S, Schyr-Ben-Haroush R, Hija A, Stolovich-Rain M et al. Control of pancreatic beta cell regeneration by glucose metabolism. Cell Metab 2011; 13: 440-449.
45. Attig L, Vige A, Gabory A, Karimi M, Beauger A, Gross MS et al. Dietary alleviation of maternal obesity and diabetes: increased resistance to diet-induced obesity transcriptional and epigenetic signatures. PLoS One 2013; 8: e66816.
46. Zhao J, Goldberg J, Bremner JD, Vaccarino V. Global DNA methylation is associated with insulin resistance: a monozygotic twin study. Diabetes 2012; 61: 542-546.
47. Yang BT, Dayeh TA, Volkov PA, Kirkpatrick CL, Malmgren S, Jing X et al. Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetes. Mol Endocrinol 2013; 26: 1203-1212.
48. Zheng H, Pritchard DM, Yang X, Bennett E, Liu G, Liu C et al. KLF4 gene expression is inhibited by the notch signaling pathway that controls goblet cell differentiation in mouse gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol 2009; 296: G490-G498.
49. Kwon MC, Koo BK, Kim YY, Lee SH, Kim NS, Kim JH et al. Essential role of CR6-interacting factor 1 (Crif1) in E74-like factor 3 (ELF3)-mediated intestinal development. J Biol Chem 2009; 284: 33634-33641.
50. Bergstrom KS, Kissoon-Singh V, Gibson DL, Ma C, Montero M, Sham HP et al. Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. PLoS Pathog 2010; 6: e1000902.
51. Wei X, Yang Z, Rey FE, Ridaura VK, Davidson NO, Gordon JI et al. Fatty acid synthase modulates intestinal barrier function through palmitoylation of mucin 2. Cell Host Microbe 2012; 11: 140-152.
52. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009; 58: 1091-1103.
53. Sakar Y, Nazaret C, Letteron P, Ait Omar A, Avenati M, Viollet B et al. Positive regulatory control loop between gut leptin and intestinal GLUT2/GLUT5 transporters links to hepatic metabolic functions in rodents. PLoS One 2009; 4: e7935.
54. Ait-Omar A, Monteiro-Sepulveda M, Poitou C, Le Gall M, Cotillard A, Gilet J et al. GLUT2 accumulation in enterocyte apical and intracellular membranes: a study in morbidly obese human subjects and ob/ob and high fat-fed mice. Diabetes 2011; 60: 2598-2607.
55. Zheng Y, Scow JS, Duenes JA, Sarr MG. Mechanisms of glucose uptake in intestinal cell lines: role of GLUT2. Surgery 2011; 151: 13-25.
56. Zambrowicz B, Freiman J, Brown PM, Frazier KS, Turnage A, Bronner J et al. LX4211, a dual SGLT1/SGLT2 inhibitor, improved glycemic control in patients with type 2 diabetes in a randomized, placebo-controlled trial. Clin Pharmacol Ther 2012; 92: 158-169.